<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(11)</volume><submitter>Wei N</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>We aimed to investigate the association of the left ventricular ejection fraction (LVEF) spectrum with 1-year clinical outcomes in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA).&lt;h4>Methods&lt;/h4>In a prospective registry for the Third China National Stroke Registry (CNSR-III), AIS or TIA patients with echocardiography records during hospitalization were recruited. All LVEFs were categorized into intervals of 5% in width. The lowest and highest intervals are ≤40% and >70%, respectively. The primary outcome was all-cause death at 1 year. Cox proportional hazards regression analysis was performed to investigate the association between baseline LVEF and clinical outcomes.&lt;h4>Results&lt;/h4>This analysis included a total of 14,053 patients. In total, 418 patients died during 1-year follow-up. Overall, LVEF ≤60% was associated with a higher risk of all-cause death compared to LVEF >60%, independent of demographic and clinical characteristics (aHR 1.29 [95% CI 1.06-1.58]; p = 0.01). The cumulative incidence of all-cause death was significantly different among the eight LVEF groups that survival declined successively with the decrease of LVEF (log-rank p ≤ 0.0001).&lt;h4>Conclusions&lt;/h4>Patients with AIS or TIA with decreased LVEF (≤60%) had a lower 1-year survival rate after onset. LVEF 50%-60% even within the normal range, may still contribute to poor outcomes in AIS or TIA. Comprehensive evaluation of cardiac function after acute ischemic cerebrovascular disease should be strengthened.</pubmed_abstract><journal>CNS neuroscience &amp; therapeutics</journal><pagination>3518-3527</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10580366</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effect of left ventricular ejection fraction Spectrum on 1-Year mortality in patients with acute ischemic stroke or transient ischemic attack.</pubmed_title><pmcid>PMC10580366</pmcid><pubmed_authors>Wei N</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Pan Y</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Xiang X</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors><pubmed_authors>Nie X</pubmed_authors><pubmed_authors>Meng X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of left ventricular ejection fraction Spectrum on 1-Year mortality in patients with acute ischemic stroke or transient ischemic attack.</name><description>&lt;h4>Aims&lt;/h4>We aimed to investigate the association of the left ventricular ejection fraction (LVEF) spectrum with 1-year clinical outcomes in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA).&lt;h4>Methods&lt;/h4>In a prospective registry for the Third China National Stroke Registry (CNSR-III), AIS or TIA patients with echocardiography records during hospitalization were recruited. All LVEFs were categorized into intervals of 5% in width. The lowest and highest intervals are ≤40% and >70%, respectively. The primary outcome was all-cause death at 1 year. Cox proportional hazards regression analysis was performed to investigate the association between baseline LVEF and clinical outcomes.&lt;h4>Results&lt;/h4>This analysis included a total of 14,053 patients. In total, 418 patients died during 1-year follow-up. Overall, LVEF ≤60% was associated with a higher risk of all-cause death compared to LVEF >60%, independent of demographic and clinical characteristics (aHR 1.29 [95% CI 1.06-1.58]; p = 0.01). The cumulative incidence of all-cause death was significantly different among the eight LVEF groups that survival declined successively with the decrease of LVEF (log-rank p ≤ 0.0001).&lt;h4>Conclusions&lt;/h4>Patients with AIS or TIA with decreased LVEF (≤60%) had a lower 1-year survival rate after onset. LVEF 50%-60% even within the normal range, may still contribute to poor outcomes in AIS or TIA. Comprehensive evaluation of cardiac function after acute ischemic cerebrovascular disease should be strengthened.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-22T17:23:36.507Z</modification><creation>2025-04-06T02:09:42.68Z</creation></dates><accession>S-EPMC10580366</accession><cross_references><pubmed>37287419</pubmed><doi>10.1111/cns.14285</doi></cross_references></HashMap>